Enovix Corporation vs Lemonade Inc — how do they compare? Enovix Corporation trades at $2.53 (market cap $549.72M), while Lemonade Inc trades at $47.02 (market cap $3.63B). The key difference: Lemonade Inc is far larger — about 6.6× Enovix Corporation's market cap, and Enovix Corporation is more actively traded (6,635,687 versus 1,544,794). Which is the better fit depends on your goals — on Pluang, investors hold Enovix Corporation for 11 Days and Lemonade Inc for 27 Days on average.
| ENVX | LMND | |
|---|---|---|
Market Cap | $549.72M | $3.63B |
Volume | 6,635,687 | 1,544,794 |
Sector | Industrials | Financials |
52-Week High | $13.19 | $96.57 |
52-Week Low | $2.50 | $43.91 |
Typical Hold Time | 11 Days | 27 Days |
Enterprise Value | $611.42M | $3.49B |
Signals from Pluang's Aura AI — not financial advice
ENVX trades at $2.55, down 5.56% on the day, reflecting a bearish technical outlook with significant selling pressure indicated by moving averages and oscillators. Fundamentally, the company is in a high-growth, pre-profitability phase, with revenue growing to $36 million in 2026 but net losses widening to -$170 million. Recent news is dominated by a sudden CEO resignation in August 2026, though the company reaffirmed its strategy and operational guidance.
The investment case hinges on the company's advanced battery technology and expansion plans, particularly in the defense and drone sectors, against a backdrop of persistent cash burn and high execution risk. Analyst consensus remains bullish with a $10.75 price target, but the stock faces near-term volatility from leadership uncertainty and the challenging path to profitability.
Lemonade (LMND) trades at $46.83, up 1.14% with a bearish technical outlook despite recent earnings beats. The company shows strong revenue growth from $257M in 2022 to $738M in 2025, though remains unprofitable with a -22.43% net margin. Analyst sentiment is evenly split between buy/hold/sell with a $67 consensus target, while institutional activity shows mixed positioning. Recent expansion into Alaska and Kentucky renters insurance and pet insurance markets supports growth trajectory.
Lemonade's path to profitability remains the key investment thesis, targeting EBITDA positivity by late 2026. The stock offers growth potential through AI-driven efficiency and market expansion but carries significant execution risk amid persistent losses. Current valuation at 3.63x sales appears reasonable for the growth profile, though technical weakness near support at $45 requires monitoring.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes.
Read more on LMND →